• Product NameHDAC9 Rabbit mAb
• Clone No.S01-8I6
• IsotypeIgG
• PurificationAffinity-chromatography
• ApplicationsWB IHC ICC/IF
• Species ReactivityHuman,Rat
• Immunogen DescriptionA synthesized peptide derived from human HDAC9
• ConjugatesUnconjugated
• ModificationUnmodification
• Alternative Names    HD7; HD9; HD7b; HDAC; HDRP; MITR; HDAC7; HDAC7B; HDAC9B; HDAC9FL
• Accession No. Swiss-Prot:Q9UKV0
  GeneID:9734
• UniprotQ9UKV0
• Gene ID9734
• Calculated MW 160 kDa
• Concentration 1.6mg/ml
• Formulation Rabbit IgG in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol.
• Storage Store at 4˚C short term. Aliquot and store at -20˚C long term. Avoid freeze/thaw cycles.

• WB 1:1000-1:5000
  IHC 1:100-1:200
  ICC/IF 1:50-1:200
  

Catalyzes the conversion of long-chain fatty acids to their active form acyl-CoA for both synthesis of cellular lipids, and degradation via beta-oxidation.Plays an important role in fatty acid metabolism in brain and the acyl-CoAs produced may be utilized exclusively for the synthesis of the brain lipid.

• Western blot analysis of HDAC9 expression in K562 cell lysate.
• All lanes use the Antibody at 1:5K dilution for 1 hour at room temperature.
• Immunohistochemical analysis of paraffin-embedded human brain, using HDAC9 Antibody.
• Immunofluorescent analysis of Hela cells, using HDAC9 Antibody.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting